Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119,358,581
-
Number of holders
-
155
-
Total 13F shares, excl. options
-
57,902,469
-
Shares change
-
+2,367,779
-
Total reported value, excl. options
-
$1,364,739,639
-
Value change
-
+$106,180,554
-
Put/Call ratio
-
1.78%
-
Number of buys
-
86
-
Number of sells
-
-61
-
Price
-
$23.57
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q2 2020
180 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q2 2020.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57,902,469 shares
of 119,358,581 outstanding shares and own 48.51% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9,361,689 shares), VANGUARD GROUP INC (4,571,208 shares), FMR LLC (3,508,826 shares), Consonance Capital Management LP (3,347,232 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (3,109,372 shares), STATE STREET CORP (3,041,032 shares), WELLINGTON MANAGEMENT GROUP LLP (3,011,620 shares), WASATCH ADVISORS INC (2,862,891 shares), Foresite Capital Management IV, LLC (1,607,292 shares), and GREAT POINT PARTNERS LLC (1,520,635 shares).
This table shows the top 155 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.